Development of Therapeutics and Diagnostics for Biodefense Program

by: Michael Saunders

The National Institutes of Health, otherwise termed as NIH, is an agency operating within the United States Department of Health and Human Services that is generally responsible for financially supporting the country's biomedical and health-related research studies.

The initiatives of the NIH are all geared towards the realization its primary agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

NIAID Category A, B, and C priority agents are pathogens that can be used as a biological weapon in acts of terrorism or sabotage. The examples of these pathogens are the ones that cause, anthrax, botulism, plague, smallpox, tularemia, hemorrhagic fevers, melioidosis, brucellosis, typhus fever, yellow fever, rabies, and several others.

The goal of the Development of Therapeutics and Diagnostics for Biodefense is to solicit applications from eligible participants in order to further explore the options and strategies that can lead to the treatment or diagnosis of the diseases that are mentioned above.

  (continued...)

Development of Therapeutics and Diagnostics for Biodefense Program
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on artist grants and children grants.

Additional Resources

category - Health Grants

Physical and Engineering Sciences in Oncology
The National Science Foundation, in close cooperation the National Cancer Institute, has recently developed the Physical and Engineering Sciences in Oncology Program wherein they intend to obtain a more thorough understanding of cancer disorders with the application of physical and engineering sciences.

---

Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program
In this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.

---

Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program
In keeping with this mission, the National Institutes of Health has partnered with the Canadian Institutes of Health Research (CIHR), the National Heart, Lung, and Blood Institute (NHLBI), and the Institute of Circulatory and Respiratory Health (ICRH) to establish the Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program.

---

Funding Opportunity Announcement: Developing Sustainable Healthy Behaviors in Children and Adolescents
The FOA is designed to encourage the use of Exploratory/Developmental Research Grant Awards in employing innovative research studies that would help in determining mechanisms that could promote and influence positive sustainable health behaviors in children and in adolescents, from birth to 18 years old.

---